• Explore /
  • Poster
  • / Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer.

Preliminary results from a single-arm, phase II study assessing the efficacy of pembrolizumab plus radiotherapy in metastatic triple negative breast cancer.

Abstract Poster

Authors

null

Alice Ho

Cedars Sinai Medical Center, Los Angeles, CA

Alice Ho, Christopher Andrew Barker, Ayca Gucalp, Lizza Lebron-Zapata, Yong Hannah Wen, Anh Phung, Molly Wilgucki, Micaela Henrich, Brittany Arnold, Sujata Patil, Heather L. McArthur

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2017 ASCO-SITC Clinical Immuno-Oncology Symposium

Session Type

Poster Session

Session Title

Poster Session A

Track

Biomarkers and Inflammatory Signatures,Humoral Immunity for Diagnosis and Therapy,Immune Checkpoints and Stimulatory Receptors,Modulating Innate Immunity,Therapies Targeting T cells

Sub Track

Clinical Trials

Clinical Trial Registration Number

NCT02730130

Citation

J Clin Oncol 35, 2017 (suppl 7S; abstract 95)

DOI

10.1200/JCO.2017.35.7_suppl.95

Abstract #

95

Poster Bd #

E4

Abstract Disclosures

Similar Posters

First Author: Heather L. McArthur

First Author: Heather L. McArthur

First Author: Shipra Gandhi

First Author: Zachary William Neil Veitch